International Kidney Cancer Collaboration with Leadership from Philadelphia - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

International Kidney Cancer Collaboration with Leadership from Philadelphia

Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050

  • December 2, 2025

  • 3 min

Share

Clinical Scorecard: International Kidney Cancer Collaboration with Leadership from Philadelphia

At a Glance

CategoryDetail
ConditionKidney Cancer
Key MechanismsIncidence, survival, genetics, and risk factors associated with kidney cancer.
Target PopulationIndividuals at risk for kidney cancer, including those with modifiable risk factors.
Care SettingUrologic oncology clinics and cancer treatment centers.

Key Highlights

  • Kidney cancer cases could double by 2050 if current trends continue.
  • Modifiable risk factors include obesity, diabetes, hypertension, lack of exercise, and smoking.
  • The R.E.N.A.L. Nephrometry Score is a widely cited tool for assessing tumor complexity.
  • The Fox Chase – Temple Urologic Institute aims to expand genetic testing and survivorship models.
  • The study emphasizes the need for prevention, early detection, and policy planning.

Guideline-Based Recommendations

Diagnosis

  • Utilize genetic testing to identify predispositions to kidney cancer.

Management

  • Implement strategies to address modifiable risk factors.

Monitoring & Follow-up

  • Establish new survivorship models reflecting projected increases in kidney cancer incidence.

Risks

  • Educate providers and patients about the impact of lifestyle factors on kidney cancer risk.

Patient & Prescribing Data

Patients with risk factors for kidney cancer and those diagnosed with the disease.

Focus on minimally invasive surgery and active surveillance for small tumors.

Clinical Best Practices

  • Promote early detection and prevention strategies.
  • Educate patients on modifiable risk factors.
  • Utilize the R.E.N.A.L. Nephrometry Score for tumor assessment.

Related Resources & Content

Original Source(s)

International Kidney Cancer Collaboration with Leadership from Philadelphia

  • December 2, 2025

Related Content

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

Menopause may be underdocumented in EHRs

Surveys captured nearly 7 times as many menopause observations as structured clinical records, with high agreement when both sources identified menopause.

CKM staging faces an early vascular test

Investigators examined Life’s Essential 8 scores and carotid ultrasonography measures across cardiovascular-kidney-metabolic stages in 1,283 young adults.